Dansky Ullmann joins the Company as MaxCyte prepares for clinical testing of its first cell therapy drug candidate Brings more than 25 years of experience in clinical oncology and drug development Gaithersburg, Maryland: MaxCyte, the global cell-based medicines and life sciences company, announced today that it has appointed Claudio Dansky Ullmann, MD, a 25+-year expert in […]
SANTA CLARA, Calif. Highlights: Jacob Thaysen named President, Life Sciences and Applied Markets Group, moving from Agilent’s Diagnostics and Genomics Group Sam Raha appointed President, Diagnostics and Genomics Group, moving from Agilent Strategy and Corporate Development Agilent Technologies Inc. (NYSE: A) today announced that Jacob Thaysen, currently, senior vice president, Agilent and president, Diagnostics and […]
MINNEAPOLIS — Bio-Techne Corporation announced today that it has hired Kim Kelderman as President, Diagnostics and Genomics, effective April 30, 2018. Mr. Kelderman will be based in California and will lead Bio-Techne’s diagnostics business; he will also drive and develop our strategic initiatives in genomics and genomics-based diagnostics. With this appointment Mr. Kelderman will become an executive officer […]
Dr. Dreismann To Also Serve as Chairman of the Executive Advisory Board; Assist MyDx In Seeking Development Partners and Strategic Partners San Diego, CA — MyDx, Inc. (OTC: MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer designed for Cannabis professionals and retail consumers to understand the chemical profile […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of Brad Kreger as Senior Vice President, Global Operations. In this role, Kreger leads global manufacturing, supply chain, demand planning, and distribution for Fluidigm. As a member of the executive leadership team reporting to President and CEO Chris Linthwaite, Kreger will be responsible for driving long-term strategic changes and process […]
The Nomination Committee proposes that Genovis should expand its Board of Directors at the 2018 Annual General Meeting. Under the proposal two directors, Lena Söderström and Peter Hein, will be elected, while Jacob Engellau will leave the Board. Lena Söderström has been CEO of Senzime AB (publ) since 2013 and was previously CEO of Isconova and […]
SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced that Patrick Kaltenbach, senior vice president, Agilent and president, Life Sciences and Analytical Group (LSAG), will leave the company on April 20, 2018. A replacement process for Kaltenbach’s position is underway, drawing on Agilent’s deep internal leadership bench. “Patrick and his team have built on Agilent’s […]
Mr. Lubniewski assumes the role after having served for seven years as Chief Business Officer TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced the promotion of John Lubniewski to President and Chief Operating Officer. Mr. Lubniewski has served as HTG’s chief business officer for the past […]
BC Platforms, a world leader in genomic data management and analytics, today announces that it has appointed Richard Kivel as its Chairman. Richard has extensive expertise in building scientifically driven companies that seek to positively impact human lives, with a focus on creating shareholder value through increasing revenues and bottom-line growth. Richard has served as […]
WALTHAM, Mass.–PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced the appointment of James M. Mock to senior vice president and chief financial officer (CFO), effective May 1, 2018. Andy Wilson, PerkinElmer’s current senior vice president and CFO, who previously announced his retirement from PerkinElmer, will remain with the Company […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
